Reply-Letter to the Editor-Glutamine dipeptide-supplemented parenteral nutrition improves the clinical outcomes of critically ill patients: A systematic evaluation of randomised controlled trials
Clin Nutr
.
2017 Aug;36(4):1182-1183.
doi: 10.1016/j.clnu.2017.03.031.
Epub 2017 Apr 7.
Authors
Peter Stehle
1
,
Björn Ellger
2
,
Dubravka Kojic
3
,
Astrid Feuersenger
4
,
Christina Schneid
5
,
John Stover
6
,
Daniela Scheiner
7
,
Martin Westphal
8
Affiliations
1
Department of Nutrition and Food Sciences, University of Bonn, Bonn, Germany. Electronic address: pstehle@uni-bonn.de.
2
Klinik für Anästhesiologie, Operative Intensivmedizin und Schmerztherapie, University Hospital Münster, Münster, Germany. Electronic address: bjoern.ellger@ukmuenster.de.
3
Department of Anesthesiology, Heidelberg University Hospital, 69120 Heidelberg, Germany. Electronic address: dubravka.kojic@med.uni-heidelberg.de.
4
Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany. Electronic address: astrid.feuersenger@fresenius-kabi.com.
5
Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany. Electronic address: Christina.schneid@fresenius-kabi.com.
6
Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany. Electronic address: john.stover@fresenius-kabi.com.
7
Fresenius Kabi Deutschland GmbH, Bad Homburg, Germany. Electronic address: daniela.scheiner@fresenius-kabi.com.
8
Fresenius Kabi AG, Bad Homburg, Germany. Electronic address: martin.westphal@fresenius-kabi.com.
PMID:
28442235
DOI:
10.1016/j.clnu.2017.03.031
No abstract available
Publication types
Letter
Comment
MeSH terms
Critical Illness*
Dipeptides
Glutamine*
Humans
Parenteral Nutrition
Parenteral Nutrition, Total
Substances
Dipeptides
Glutamine